Skip to main content
. 2015 Oct 26;10:196. doi: 10.1186/s13000-015-0428-4

Table 8.

Number of studies, patients and their distributions included in each analysis by the immunohistochemistry technique

Studies Patients TP FP FN TN
CK19 24 4239 1834 436 464 1505
CD56 10 1226 158 418 619 31
HMBE-1 26 4691 1824 311 563 1993
GALECT 3 38 5426 2344 442 458 2182